43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 10
12:54 UTC
|
CPAY
Corpay
|
◎ Target | Ramsey El-Assal not yet tracked | Overweight | $415.00→ $480.00+15.7% |
|
Aug 10
12:54 UTC
|
CCSI
Consensus Cloud Solutions
|
◎ Target | David Larsen ★★★★☆ #952 | Buy | $45.00→ $50.00+11.1% |
|
Aug 10
12:54 UTC
|
CARG
CarGurus
|
◎ Target | John Babcock ★★★☆☆ #1849 | Overweight | $40.00→ $41.00+2.5% |
|
Aug 10
12:54 UTC
|
BWA
BorgWarner
|
◎ Target | Dan Levy ★★★☆☆ #1950 | Overweight | $83.00→ $85.00+2.4% |
|
Aug 10
12:54 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Whitney Ijem ★★☆☆☆ #2622 | Buy | $111.00→ $114.00+2.7% |
|
Aug 10
12:54 UTC
|
BETR
Better Home & Finance
|
◎ Target | Douglas Harter ★★☆☆☆ #2410 | Buy | $36.00→ $23.00-36.1% |
|
Aug 10
12:54 UTC
|
BDSX
Biodesix
|
◎ Target | Kyle Mikson not yet tracked | Buy | $27.00→ $35.00+29.6% |
|
Aug 10
12:54 UTC
|
BAER
Bridger Aerospace Group
|
◎ Target | Austin Moeller ★☆☆☆☆ #2923 | Buy | $4.50→ $4.00-11.1% |
|
Aug 10
12:54 UTC
|
APTV
Aptiv
|
◎ Target | Dan Levy ★★★☆☆ #1950 | Overweight | $73.00→ $65.00-11.0% |
|
Aug 10
12:54 UTC
|
ANIP
ANI Pharmaceuticals
|
◎ Target | Gary Nachman ★★★☆☆ #1725 | Hold | $91.00→ $90.00-1.1% |
|
Aug 10
12:54 UTC
|
ALRM
Alarm.com
|
◎ Target | Saket Kalia ★★★★★ #320 | Equal Weight | $55.00→ $60.00+9.1% |
|
Aug 10
12:54 UTC
|
AGYS
Agilysys
|
◎ Target | Mayank Tandon ★★★★★ #154 | Buy | $130.00→ $135.00+3.8% |
|
Aug 10
12:54 UTC
|
ADNT
Adient
|
◎ Target | Dan Levy ★★★☆☆ #1950 | Equal Weight | $29.00→ $25.00-13.8% |
|
Aug 10
12:54 UTC
|
ABNB
Airbnb
|
◎ Target | Brian Pitz ★★★☆☆ #1128 | Market Perform | $146.00→ $165.00+13.0% |
|
Aug 10
10:53 UTC
|
WPP
WPP
|
◎ Target | firm only | Neutral | GBX 285→ GBX 430+50.9% |
|
Aug 10
10:53 UTC
|
SHC
Shaftesbury Capital
|
◎ Target | firm only | Buy | GBX 151→ GBX 166+9.9% |
|
Aug 10
10:53 UTC
|
QQ
QinetiQ Group
|
◎ Target | firm only | Sec→ r Perform | GBX 490→ GBX 570+16.3% |
|
Aug 10
10:53 UTC
|
OXB
Oxford Biomedica
|
◎ Target | firm only | Outperform | GBX 1,140→ GBX 900-21.1% |
|
Aug 10
10:53 UTC
|
MNDI
Mondi
|
◎ Target | firm only | Buy | GBX 820→ GBX 1,040+26.8% |
|
Aug 10
10:53 UTC
|
IBST
Ibstock
|
◎ Target | firm only | Hold | GBX 115→ GBX 90-21.7% |
|
Aug 10
10:53 UTC
|
HBR
Harbour Energy
|
◎ Target | firm only | Neutral | GBX 260→ GBX 280+7.7% |
|
Aug 10
10:53 UTC
|
FORT
Forterra
|
◎ Target | firm only | Buy | GBX 160→ GBX 181+13.1% |
|
Aug 10
10:53 UTC
|
DGE
Diageo
|
◎ Target | firm only | Buy | GBX 2,000→ GBX 2,200+10.0% |
|
Aug 10
10:53 UTC
|
CHG
Chemring Group
|
◎ Target | firm only | Outperform | GBX 580→ GBX 680+17.2% |
|
Aug 10
08:53 UTC
|
NICL
Nichols
|
◎ Target | firm only | Buy | GBX 1,720→ GBX 1,750+1.7% |
|
Aug 09
00:49 UTC
|
ZYME
Zymeworks
|
◎ Target | Eva Fortea Verdejo ★★★☆☆ #1058 | Overweight | $37.00→ $40.00+8.1% |
|
Aug 09
00:49 UTC
|
ZYME
Zymeworks
|
◎ Target | Gregory Renza ★★★☆☆ #1489 | Buy | $31.00→ $32.00+3.2% |
|
Aug 09
00:49 UTC
|
ZVRA
Zevra Therapeutics
|
◎ Target | Eddie Hickman ★★★★★ #106 | Buy | $24.00→ $23.00-4.2% |
|
Aug 09
00:49 UTC
|
ZTS
Zoetis
|
◎ Target | Chris Schott ★★★★☆ #531 | Overweight | $130.00→ $115.00-11.5% |
|
Aug 09
00:49 UTC
|
ZTS
Zoetis
|
◎ Target | Andrea Alfonso ★★★☆☆ #1136 | Neutral | $85.00→ $80.00-5.9% |
|
Aug 09
00:49 UTC
|
ZLAB
Zai Lab
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2300 | Buy | $44.00→ $45.00+2.3% |
|
Aug 09
00:49 UTC
|
ZG
Zillow Group
|
◎ Target | Thomas Champion ★★★☆☆ #1302 | Overweight | $55.00→ $46.00-16.4% |
|
Aug 09
00:49 UTC
|
ZG
Zillow Group
|
◎ Target | Alec Brondolo ★★★☆☆ #1538 | Equal Weight | $46.00→ $35.00-23.9% |
|
Aug 09
00:49 UTC
|
ZG
Zillow Group
|
◎ Target | Andrew Boone ★★★☆☆ #1372 | Market Outperform | $75.00→ $46.00-38.7% |
|
Aug 09
00:49 UTC
|
Z
Zillow Group
|
◎ Target | Ryan Tomasello ★★★★★ #146 | Market Perform | $37.00→ $34.00-8.1% |
|
Aug 09
00:49 UTC
|
XYZ
Block
|
◎ Target | Stephen Biggar ★★★☆☆ #1222 | Buy | $86.00→ $103.00+19.8% |
|
Aug 09
00:49 UTC
|
XYZ
Block
|
◎ Target | firm only | Buy | $115.00→ $125.00+8.7% |
|
Aug 09
00:49 UTC
|
XOM
ExxonMobil
|
◎ Target | Jason Gabelman ★★★★☆ #590 | Buy | $155.00→ $168.00+8.4% |
|
Aug 09
00:49 UTC
|
XENE
Xenon Pharmaceuticals
|
◎ Target | Brian Abrahams ★★★☆☆ #1905 | Outperform | $82.00→ $81.00-1.2% |
|
Aug 09
00:49 UTC
|
WTS
Watts Water Technologies
|
◎ Target | Jeffrey Reive not yet tracked | Sec→ r Perform | $350.00→ $417.00+19.1% |
|
Aug 09
00:49 UTC
|
WTS
Watts Water Technologies
|
◎ Target | William Grippin ★★★☆☆ #2191 | Overweight | $414.00→ $425.00+2.7% |
|
Aug 09
00:49 UTC
|
WSP
WSP Global
|
◎ Target | firm only | Outperform | C$207.00→ C$219.00+5.8% |
|
Aug 09
00:49 UTC
|
WSP
WSP Global
|
◎ Target | firm only | Buy | C$372.00→ C$369.00-0.8% |
|
Aug 09
00:49 UTC
|
WSP
WSP Global
|
◎ Target | firm only | Outperform | C$330.00→ C$325.00-1.5% |
|
Aug 09
00:49 UTC
|
WRBY
Warby Parker
|
◎ Target | Mark Carden ★★★★☆ #544 | Neutral | $27.00→ $28.00+3.7% |
|
Aug 09
00:49 UTC
|
WRBY
Warby Parker
|
◎ Target | Andrew Boone ★★★☆☆ #1372 | Market Outperform | $30.00→ $29.00-3.3% |
|
Aug 09
00:49 UTC
|
WPP
WPP
|
◎ Target | firm only | Neutral | GBX 350→ GBX 390+11.4% |
|
Aug 09
00:49 UTC
|
WMS
Advanced Drainage Systems
|
◎ Target | Jeffrey Reive not yet tracked | Outperform | $170.00→ $178.00+4.7% |
|
Aug 09
00:49 UTC
|
WIZZ
Wizz Air
|
◎ Target | firm only | Neutral | GBX 1,200→ GBX 1,150-4.2% |
|
Aug 09
00:49 UTC
|
WEST
Westrock Coffee
|
◎ Target | Sarang Vora ★★☆☆☆ #2517 | Outperform | $9.00→ $10.00+11.1% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.